ArticleSensors (Basel, Switzerland)2026
An Ultrasensitive Electrochemical Biosensor for Nucleic Acid Detection Based on Silver Nanoflower-Stem-Loop Probes.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Nucleic acids are critical biomarkers that provide essential information throughout disease progression, making their detection critical to early diagnosis of both infectious and non-infectious diseases. However, existing detection methods, including classical analytical techniques and even most reported biosensors, are often constrained by complex procedures, high costs, and limited sensitivity, with the majority operating at the femtomolar level and failing to achieve single-molecule detection needed for early-stage diagnosis. Here, we report an electrochemical biosensor based on silver nanoflowers (AgNFs) integrated with stem-loop probes (SPs) for universal nucleic acid detection, using Norovirus RNA as a model target to validate the platform. The SPs serve as critical elements in a signal amplification system, converting target binding into a biotin-streptavidin recognition event, which leads to the accumulation of AgNFs-SP complexes on laser-induced graphene (LIG) electrodes and generates a strong electrochemical signal. Under optimized conditions with a 50 min hybridization incubation (total assay time ~60 min), the sensor exhibits a linear response to Norovirus RNA concentrations from 1 aM to 10 fM, with a measured detection limit of 1 aM, achieving single-molecule-level detection capability. For applications requiring faster turnaround, a 20 min hybridization incubation (~30 min total assay time) shifts the linear range to 0.1 fM-1 pM with a measured detection limit of 0.1 fM, offering more rapid quantification when the maximum sensitivity is not required. The proposed biosensor is cost-effective, amenable to miniaturization, and designed as a versatile platform adaptable to other nucleic acid targets by simply modifying the probe sequence, showing broad potential for early diagnosis of various diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.